\-\ Texto\\:\\ \ \(0\)\
\-\ lab\\ work\\ for\\ the\\ patient\\ was\\ unremarkable\\ to\\ include\\ negative\\ hiv\\ and\\ lyme\\ antibody\\.\\ \\ on\\ physical\\ exam\\ the\\ patient\\ complained\\ of\\ headache\\.\\ \\ he\\ was\\ mildly\\ disoriented\\ and\\ ataxic\\.\ \(0\)\
\-\ patient\\ was\\ treated\\ with\\ high\\-dose\\ steroids\\.\\ \\ the\\ patient\\ demonstrated\\ gradual\\ improvement\\ in\\ symptoms\\ 2\\-weeks\\ following\\ initial\\ presentation\\.\ \(0\)\
\-\ image\\ findings\\ demonstrate\\ bilateral\\,\\ symmetric\\ abnormal\\ increased\\ t2\\ signal\\ within\\ the\\ white\\ matter\\ of\\ the\\ superior\\ cerebellum\\.\\ \\ there\\ is\\ mild\\ enhancement\\ of\\ the\\ affected\\ white\\ matter\\.\\ \\ there\\ is\\ no\\ mass\\ effect\\,\\ hemorrhage\\ or\\ other\\ lesions\\ within\\ the\\ brain\\ parenchyma\\.\\ \\ diffusion\\ weighted\\ images\\ are\\ negative\\ for\\ acute\\ infarct\\.\\ \\ gradient\\ echo\\ images\\ demonstrate\\ no\\ evidence\\ of\\ old\\ hemorrhage\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ acute\\ disseminated\\ encephalomyelitis\ \(7\)\
\-\ multiple\\ sclerosis\ \(41\)\
\-\ sarcoid\ \(163\)\
\-\ 26\\-year\\ old\\ active\\ duty\\ male\\ presented\\ with\\ acute\\ onset\\ of\\ ataxia\\,\\ dysarthria\\,\\ headache\\,\\ and\\ lethargy\\.\ \(1\)\
\-\ this\\ patient\\ is\\ a\\ 26\\-year\\ old\\ active\\ duty\\ male\\ who\\ presented\\ with\\ acute\\ onset\\ of\\ ataxia\\,\\ dysarthria\\,\\ headaches\\,\\ and\\ lethargy\\.\\ \\ significant\\ past\\ medical\\ history\\ included\\ vaccination\\ against\\ smallpox\\,\\ measles\\ and\\ tetanus\\ 6\\-days\\ prior\\ to\\ his\\ presentation\\.\\ \\ \\ patient\\ was\\ treated\\ supportively\\ as\\ well\\ as\\ with\\ high\\-dose\\ steroids\\.\\ \\ 2\\-weeks\\ following\\ initial\\ presentation\\,\\ the\\ patient\\â\\€\\™s\\ symptoms\\ are\\ slowly\\ improving\\ with\\ only\\ mild\\ dysarthria\\ remaining\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dysarthria\\:\\ 0\\.29606939178032604\ \(0\)\
\-\ acute\\:\\ 0\\.22160609620954183\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.19189143345067158\ \(0\)\
\-\ patient\\:\\ 0\\.18653494479525606\ \(0\)\
\-\ lethargy\\:\\ 0\\.18240506919217567\ \(0\)\
\-\ disseminated\\:\\ 0\\.17746858115951464\ \(0\)\
\-\ presentation\\:\\ 0\\.16919857956711803\ \(0\)\
\-\ ataxia\\:\\ 0\\.15911067685743763\ \(0\)\
\-\ duty\\:\\ 0\\.15537483309037622\ \(0\)\
\-\ steroids\\:\\ 0\\.1439621322679534\ \(0\)\
\-\ the\\:\\ 0\\.1307846835568485\ \(0\)\
\-\ smallpox\\:\\ 0\\.12520096323380883\ \(0\)\
\-\ supportively\\:\\ 0\\.12520096323380883\ \(0\)\
\-\ matter\\:\\ 0\\.12476631403015156\ \(0\)\
\-\ active\\:\\ 0\\.12167949397594563\ \(0\)\
\-\ was\\:\\ 0\\.1142142356354013\ \(0\)\
\-\ tetanus\\:\\ 0\\.11303142731718292\ \(0\)\
\-\ headache\\:\\ 0\\.11295863967873097\ \(0\)\
\-\ measles\\:\\ 0\\.1111135479567906\ \(0\)\
\-\ initial\\:\\ 0\\.10992410363082201\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.10970893018849566\ \(0\)\
\-\ white\\:\\ 0\\.10811072611239118\ \(0\)\
\-\ ataxic\\:\\ 0\\.10790859065754667\ \(0\)\
\-\ vaccination\\:\\ 0\\.10653967340828234\ \(0\)\
\-\ onset\\:\\ 0\\.10521968847612935\ \(0\)\
\-\ treated\\:\\ 0\\.10204076246650735\ \(0\)\
\-\ negative\\:\\ 0\\.10144511299516194\ \(0\)\
\-\ disoriented\\:\\ 0\\.10028730437608896\ \(0\)\
\-\ following\\:\\ 0\\.09830091542158642\ \(0\)\
\-\ of\\:\\ 0\\.09620051115252669\ \(0\)\
\-\ improving\\:\\ 0\\.09594571672533579\ \(0\)\
\-\ presented\\:\\ 0\\.09555434843469912\ \(0\)\
\-\ antibody\\:\\ 0\\.09364275370573705\ \(0\)\
\-\ mild\\:\\ 0\\.09288803968404259\ \(0\)\
\-\ gradual\\:\\ 0\\.09261640574783214\ \(0\)\
\-\ lyme\\:\\ 0\\.08991545665723624\ \(0\)\
\-\ symptoms\\:\\ 0\\.08965535812212572\ \(0\)\
\-\ gradient\\:\\ 0\\.08599021004498442\ \(0\)\
\-\ demonstrate\\:\\ 0\\.08518669820078963\ \(0\)\
\-\ and\\:\\ 0\\.0846495804095522\ \(0\)\
\-\ against\\:\\ 0\\.0829106924960728\ \(0\)\
\-\ hiv\\:\\ 0\\.08102434500370684\ \(0\)\
\-\ slowly\\:\\ 0\\.08080506196389506\ \(0\)\
\-\ with\\:\\ 0\\.08021499244584751\ \(0\)\
\-\ complained\\:\\ 0\\.07896902191391547\ \(0\)\
\-\ remaining\\:\\ 0\\.07786364894170114\ \(0\)\
\-\ sarcoid\\:\\ 0\\.07683730098379626\ \(0\)\
\-\ echo\\:\\ 0\\.07587942876998015\ \(0\)\
\-\ images\\:\\ 0\\.07579653821172955\ \(0\)\
\-\ within\\:\\ 0\\.07546924047907916\ \(0\)\
\-\ cerebellum\\:\\ 0\\.07527459160771394\ \(0\)\
\-\ lab\\:\\ 0\\.07400021096756812\ \(0\)\
\-\ male\\:\\ 0\\.072957140188773\ \(0\)\
\-\ old\\:\\ 0\\.07274431766339415\ \(0\)\
\-\ improvement\\:\\ 0\\.07151771110875976\ \(0\)\
\-\ included\\:\\ 0\\.07084955528354368\ \(0\)\
\-\ symmetric\\:\\ 0\\.07021110528094852\ \(0\)\
\-\ diffusion\\:\\ 0\\.06901351523356408\ \(0\)\
\-\ infarct\\:\\ 0\\.0681766128838836\ \(0\)\
\-\ affected\\:\\ 0\\.0673858025120929\ \(0\)\
\-\ is\\:\\ 0\\.06731159794761371\ \(0\)\
\-\ work\\:\\ 0\\.06679948599728956\ \(0\)\
\-\ parenchyma\\:\\ 0\\.06655535388533262\ \(0\)\
\-\ mildly\\:\\ 0\\.06615746805029218\ \(0\)\
\-\ as\\:\\ 0\\.065828706587925\ \(0\)\
\-\ there\\:\\ 0\\.06519971145479432\ \(0\)\
\-\ are\\:\\ 0\\.06217772857149317\ \(0\)\
\-\ weighted\\:\\ 0\\.06111333164300409\ \(0\)\
\-\ headaches\\:\\ 0\\.06111333164300409\ \(0\)\
\-\ sclerosis\\:\\ 0\\.05835724712916445\ \(0\)\
\-\ effect\\:\\ 0\\.05747310587868841\ \(0\)\
\-\ unremarkable\\:\\ 0\\.05492609995654586\ \(0\)\
\-\ past\\:\\ 0\\.053330482801765416\ \(0\)\
\-\ no\\:\\ 0\\.053285673902731014\ \(0\)\
\-\ superior\\:\\ 0\\.05326636323046489\ \(0\)\
\-\ image\\:\\ 0\\.05239750811984772\ \(0\)\
\-\ medical\\:\\ 0\\.052070052773273943\ \(0\)\
\-\ only\\:\\ 0\\.051185472247642506\ \(0\)\
\-\ brain\\:\\ 0\\.051075200994908664\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0503522254080376\ \(0\)\
\-\ his\\:\\ 0\\.04968881838766468\ \(0\)\
\-\ for\\:\\ 0\\.049664956744822644\ \(0\)\
\-\ abnormal\\:\\ 0\\.04922269303548048\ \(0\)\
\-\ include\\:\\ 0\\.04874784780155691\ \(0\)\
\-\ he\\:\\ 0\\.04851618535805801\ \(0\)\
\-\ significant\\:\\ 0\\.04730481367508814\ \(0\)\
\-\ enhancement\\:\\ 0\\.04715771755277389\ \(0\)\
\-\ t2\\:\\ 0\\.04713682626164726\ \(0\)\
\-\ lesions\\:\\ 0\\.04705356365097564\ \(0\)\
\-\ evidence\\:\\ 0\\.04650382323217241\ \(0\)\
\-\ signal\\:\\ 0\\.046444019842021296\ \(0\)\
\-\ who\\:\\ 0\\.04634489757063691\ \(0\)\
\-\ prior\\:\\ 0\\.04584020812973997\ \(0\)\
\-\ physical\\:\\ 0\\.04442454889705749\ \(0\)\
\-\ increased\\:\\ 0\\.044304069675551706\ \(0\)\
\-\ bilateral\\:\\ 0\\.044032425453314906\ \(0\)\
\-\ other\\:\\ 0\\.04254777711044137\ \(0\)\
\-\ exam\\:\\ 0\\.041243809192572305\ \(0\)\
\-\ to\\:\\ 0\\.04096488294840663\ \(0\)\
\-\ findings\\:\\ 0\\.040435943404183695\ \(0\)\
\-\ multiple\\:\\ 0\\.0400739464899329\ \(0\)\
\-\ well\\:\\ 0\\.03967110823149281\ \(0\)\
\-\ history\\:\\ 0\\.031302159493630834\ \(0\)\
\-\ mass\\:\\ 0\\.031295229331799256\ \(0\)\
\-\ or\\:\\ 0\\.02850213062989023\ \(0\)\
\-\ this\\:\\ 0\\.02815276419836744\ \(0\)\
\-\ on\\:\\ 0\\.024744390024428953\ \(0\)\
\-\ in\\:\\ 0\\.02038162693968788\ \(0\)\
